Aspira Women’s Health Selected as Spokesperson for Investor Catalyst Hub Page 1

The “Spoke” designation recognizes Aspira’s position as an innovator in women’s health and provides new opportunities for funding, thought leadership and networking with other leaders in the healthcare industry.

AUSTIN, Texas, Sept. 5, 2024 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bioanalytical-based women’s health company focused on developing diagnostic tools for gynecological diseases, today announced it has been selected as a spokesperson for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H). Based in the Greater Boston area and managed by VentureWell, the Investor Catalyst Hub aims to accelerate the commercialization of breakthrough and accessible biomedical solutions. It utilizes an innovative hub-and-spoke model designed to reach a broad range of nonprofit and minority-serving institutions, with the ultimate goal of delivering scalable healthcare outcomes for all Americans.